STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

LQDA Form 144: Paul Manning Plans to Sell 947,328 Shares ($26.1M)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Paul Manning filed a Form 144 reporting proposed and recent sales of Liquidia Corporation (LQDA) common stock. The filing lists a proposed sale of 947,328 shares with an aggregate market value of $26,146,252.80, using Fidelity Brokerage Services (NASDAQ) with an approximate sale date of 08/29/2025. The filer disclosed prior acquisitions between 2018 and 2022 totaling reported lots of shares, and a sale on 08/28/2025 of 154,337 shares that generated $4,312,469.02 in gross proceeds. The filer certifies no undisclosed material adverse information.

Positive

  • None.

Negative

  • Planned sale of 947,328 shares with aggregate market value of $26,146,252.80 (approximate sale date 08/29/2025)
  • Recent sale on 08/28/2025 of 154,337 shares generating $4,312,469.02 in gross proceeds

Insights

TL;DR: Insider reported a planned sale of 947,328 shares (~1.1% of outstanding), with a recent 154,337-share sale for $4.31M; impact appears limited.

The filing discloses a planned sale that represents roughly 1.1% of the company’s reported outstanding common shares (947,328 of 86,091,454). The recent executed sale of 154,337 shares produced $4,312,469.02 of gross proceeds. These quantities are below common materiality thresholds used by investors (e.g., 5%), so the transactions are unlikely to materially affect share supply or valuation on their own. Monitor for additional filings or larger aggregated sales.

TL;DR: Reported sales are disclosed per Rule 144; the signer affirms no undisclosed material information, making this a routine compliance disclosure.

The Form 144 follows Rule 144 disclosure requirements and lists acquisition dates and payment methods for the shares being sold. The filer’s certification that no material, nonpublic information is known is standard. From a governance perspective, timely public disclosure of insider sales supports market transparency; there is no indication in this filing of unusual trading plans, restrictions, or unresolved compliance issues.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

Who is the filer on the Form 144 for Liquidia (LQDA)?

The filer is Paul Manning, listed with an address tied to Liquidia Corporation.

How many Liquidia shares does the Form 144 propose to sell?

The Form 144 reports a proposed sale of 947,328 common shares with aggregate market value $26,146,252.80.

Was any insider sale already executed before this filing?

Yes, the filing discloses a sale on 08/28/2025 of 154,337 shares for gross proceeds of $4,312,469.02.

On which exchange and through which broker are the shares to be sold?

The filing lists Fidelity Brokerage Services LLC and the exchange as NASDAQ.

What portion of outstanding shares does the proposed sale represent?

The filing reports 86,091,454 shares outstanding; the proposed 947,328 share sale is about 1.1% of that total.
Liquidia Corporation

NASDAQ:LQDA

LQDA Rankings

LQDA Latest News

LQDA Latest SEC Filings

LQDA Stock Data

2.84B
74.36M
13.61%
70.58%
19.88%
Biotechnology
Pharmaceutical Preparations
Link
United States
MORRISVILLE